603288:SSEFoshan Haitian Flavouring and Food Company Ltd. Class A Analysis
Data as of 2026-03-16 - not real-time
CN¥38.51
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Foshan Haitian delivers strong profitability with high gross and operating margins, and a robust cash pile that dwarfs its modest debt load. The company’s earnings per share are trending upward, supported by solid free cash flow generation, while its dividend yield remains attractive despite an unusually high payout ratio. Technically, the stock sits near a key resistance level, with short‑term moving averages aligned in a down‑trend but a bullish MACD signal and rising volume suggesting lingering buying interest. However, valuation metrics such as price‑to‑earnings and price‑to‑book are markedly elevated, and a discounted cash flow model places the fair value well below the current market price, indicating that the market may be pricing in overly optimistic expectations.
Given the modest revenue growth and the sector’s defensive nature, the upside appears limited unless the company can accelerate top‑line expansion or improve dividend sustainability. Investors should weigh the attractive cash generation and dividend against the valuation premium and the potential strain of maintaining a high payout ratio.
Given the modest revenue growth and the sector’s defensive nature, the upside appears limited unless the company can accelerate top‑line expansion or improve dividend sustainability. Investors should weigh the attractive cash generation and dividend against the valuation premium and the potential strain of maintaining a high payout ratio.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- price hovering at a technical resistance zone
- bullish MACD despite a bearish moving‑average alignment
- high dividend yield offset by a risky payout ratio
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- steady cash generation and low leverage
- modest revenue growth in a stable consumer‑defensive sector
- valuation still above intrinsic estimates
Long Term
> 3 yearsCautious
Model confidence: 4/10
Key Factors
- significant valuation gap versus discounted cash‑flow fair value
- high dividend payout may become unsustainable
- limited growth prospects to justify premium pricing
Key Metrics & Analysis
Financial Health
Revenue Growth2.50%
Profit Margin24.36%
P/E Ratio31.8
ROE19.61%
ROA11.30%
Debt/Equity0.56
P/B Ratio5.7
Op. Cash FlowCN¥7.2B
Free Cash FlowCN¥5.5B
Technical Analysis
TrendBearish
RSI65.3
SupportCN¥35.25
ResistanceCN¥38.72
MA 20CN¥36.56
MA 50CN¥36.79
MA 200CN¥38.67
MACDBullish
VolumeIncreasing
Fear & Greed Index74.82
Valuation
Fair ValueCN¥19.40
GradeOvervalued
TypeValue
Dividend Yield2.96%
Risk Assessment
Beta-0.01
Volatility27.39%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.